Navigation Links
GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy

idates, or collaborators, risks relating to the commercialization, if any, of GenVec's proposed product candidates (such as marketing, regulatory, patent, product liability, supply, competition and other risks); dependence on the efforts of third parties; dependence on intellectual property; and risks that we may lack the financial resources and access to capital to fund our operations. Further information on the factors and risks that could affect GenVec's business, financial conditions and results of operations, are contained in GenVec's filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. These forward-looking statements speak only as of the date of this press release, and GenVec assumes no duty to update forward-looking statements.

Contact

GenVec, Inc.
Sharon L. Weinstein, 240-632-5511
sweinstein@genvec.com


'"/>




Page: 1 2 3

Related medicine technology :

1. GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO
2. GenVec Presents Research on New Ad35 Adenovector at ARVO
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:9/22/2014)... , Sept. 22, 2014 /CNW/ - T-Bird Pharma ... focused on developing premium quality medical marijuana products, is ... Biomedical Inc. ("Thunderbird"), has signed a definitive lease agreement ... , BC.  The facility has 28,966 square feet ... 14,500 square feet of mezzanine space for a total ...
(Date:9/22/2014)... Pa. , Sept. 22, 2014  Inovio ... today it has initiated a phase I clinical ... will evaluate the safety, tolerability, and immunogenicity of ... (HPV-6), which causes most aerodigestive cancers. ... throat, vocal cords, and parts of the esophagus ...
(Date:9/22/2014)... NEW YORK , Sept. 22, ... has signed an exclusive, global license agreement with ... commercialization of its proprietary plasma fractionation process. Concurrently, ... and its intention to strategically refocus and rebrand ... plans to pursue a national listing for its ...
Breaking Medicine Technology:T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 2Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 5Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 6
... $300,000 as Title Sponsor of ZENPEP(R) CF Cycle for Life , ... BETHESDA, Md. , May 3 Thousands of cyclists will take ... tour in 18 cities across the country to support research to find new therapies and a ... San Francisco on June 26 . , ...
... American Pacific Corporation ( APFC) ("AMPAC") ... on Thursday, May 6, 2010 , immediately after the market closes, followed ... , , , ... invites you to participate in the teleconference to discuss the financial results ...
Cached Medicine Technology:Cystic Fibrosis Foundation Launches National Cycling Series to Benefit Critical Research and Care 2Cystic Fibrosis Foundation Launches National Cycling Series to Benefit Critical Research and Care 3American Pacific to Release Financial Results and Hold Fiscal 2010 Second Quarter Investor Teleconference 2
(Date:9/22/2014)... WI (PRWEB) September 22, 2014 ... in the United States, promotes National Self-Improvement ... believes that all individuals should have access to ... in aging. , The demand for products that ... longer than ever before. For over six years, ...
(Date:9/22/2014)... Va. (PRWEB) September 22, 2014 ... the nation’s leading nonprofit authority on the ... healthcare information exchange, announced findings from its recent ... Health Plan Identifier (HPID) within electronic transactions adopted ... (HIPAA). WEDI conducted the survey from August 20 ...
(Date:9/22/2014)... MONDAY, Sept. 22, 2014 (HealthDay News) -- Two new ... Administration (FDA) may provide some relief for people with ... to a new study. One device -- the ... other device -- the Cerena -- is meant to ... FDA news release. "Patients have been looking for ...
(Date:9/22/2014)... 22, 2014 Pain does not need to ... a user- and reader-friendly book designed to guide the individual ... living. This inspirational book is written to help the reader ... a way to regain a pain-free life — a daily ... pain. , Chronic pain has become an epidemic, with over ...
(Date:9/22/2014)... 22, 2014 PCI (Project Concern ... to equip women around the world with tools and ... the Women Empowered (WE) Initiative announced at the CGI ... groups to pool their savings, invest in their own ... solution to ending poverty in the world, and through ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 2Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 3
... a young Indian American is hard put to find a ... South Asians are listed in the US Bone Marrow registry. ... a disease known as Acute Myelogenous Leukemia (or AML), a ... Asian community has come together nationwide to help him and ...
... International Diabetes Federation (IDF) today called for projects that ... with diabetes and to implement practical solutions for improving ... as BRIDGES (Bringing Research in Diabetes to Global Environments ... Congress in Cape Town, South Africa and was officially ...
... ice sheet to break up, even though the air over ... at least a century, according to a new study ... ,As part of their study, the team led by ... how high the ice had deposited boulders in Antarctica's Framnes ...
... Echinacea, a medicinal herb that came to prominence thanks to its ... catching a cold, a wide-scale study has confirmed. ,Taking ... percent and may also shorten the duration of a cold almost ... Sunday in the July issue of the journal The Lancet Infectious ...
... studies have found that new adjuvant treatments for breast ... Published in the August 1, 2007 issue of Cancer, ... studies looked at the cost-effectiveness of different drugs for ... ,In a Canadian economic study of estrogen ...
... Six World Heritage sites, including Mount Everest, could be at ... experts and groups . ,Urging the United Nations ... the Climate Justice Programme have petitioned the global body to ... that have signed the UN World Heritage Convention have a ...
Cached Medicine News:Health News:South Asians Seek Bone Marrow for Young Indian American 2Health News:The International Diabetes Federation Launches US$ 10 Million Grant to Improve Diabetes Care 2Health News:The International Diabetes Federation Launches US$ 10 Million Grant to Improve Diabetes Care 3Health News:Sioux Herb Confirmed as Shield Against Colds 2Health News:New Adjuvant Breast Cancer Treatments Found Cost-effective 2Health News:Everest, Five Other World Heritage Sites Face Climate Change Risk 2
Indications For Usage: ,Airway management during anesthesia or short-term surgical procedures....
Indications For Usage: , When patient's head is in an extended or flexed position When patient will be turned over. , Long-term cases where maintenance of an airway is critical. , Neurosurgical pr...
Indications For Usage: ,Airway management during pediatric surgical procedures and intensive care....
... Detector/Clamp adds air detection and automatic clamping capability ... Fluid Warmer., ,The potential of air embolism ... known. Currently, health care professionals rely primarily on ... has lead to the safe use of the ...
Medicine Products: